ATS 2018 International Conference

Incidence of Chronic Obstructive Pulmonary Disease Symptom-Defined Exacerbations: Exploratory Analysis from a Long-Term Open-Label Active-Controlled Safety Trial of Nebulized Glycopyrrolate/eFlow® CS [Board No. P1340]

Location: Board no. P1340

Session Type: Thematic Poster Session

Monday

May

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Vaidyanathan Ganapathy

PhD
Sunovion Pharmaceuticals;Sunovion Pharmaceuticals Inc.

Edward M. Kerwin

phd
Clinical Research Institute;Clinical Research Institute of Southern Oregon, PC;Crisor, LLC c/o Clinical Research Institute of Southern Oregon, Inc.

Lindsey Murray

PhD
Evidera

Krithika Rajagopalan

PhD
Sunovion Pharmaceuticals Inc.

View Abstract

Incidence of Chronic Obstructive Pulmonary Disease Symptom-Defined Exacerbations: Exploratory Analysis from a Long-Term Open-Label Active-Controlled Safety Trial of Nebulized Glycopyrrolate/eFlow® CS

Parent Sessions

B33 - COPD: MAINTENANCE THERAPY
05-21-2018 9:15 AM - 4:15 PM

Event